Avis juridique important

|

31966L0600

Council Directive 66/600/EEC of 25 October 1966 amending the Council Directive of 26 June 1964 on animal health problems affecting intra-Community trade in bovine animals and swine

Official Journal 192 , 27/10/1966 P. 3294 - 3302 Danish special edition: Series I Chapter 1965-1966 P. 0204  English special edition: Series I Chapter 1965-1966 P. 0234  Greek special edition: Chapter 03 Volume 2 P. 0044  Spanish special edition: Chapter 03 Volume 1 P. 0225  Portuguese special edition Chapter 03 Volume 1 P. 0225

COUNCIL DIRECTIVE of 25 October 1966 amending the Council Directive of 26 June 1964 on animal health problems affecting intra-Community trade in bovine animals and swine (66/600/EEC)  THE COUNCIL OF THE EUROPEAN ECONOMIC COMMUNITY,  Having regard to the Treaty establishing the European Economic Community, and in particular Articles 43 and 100 thereof;  Having regard to the proposal from the Commission;  Having regard to the Opinion of the European Parliament 1;  Having regard to the Opinion of the Economic and Social Committee;  Whereas the Council Directive of 26 June 1964 2 on animal health problems affecting intra-Community trade in bovine animals and swine entered into force on 30 June 1965;  Whereas that Directive constitutes the first stage of a harmonisation designed to eliminate obstacles to trade arising from differences between the veterinary provisions of Member States, in particular as regards animal health measures;  Whereas the incorporation of that Directive in the laws of each Member State has shown that its provisions should be adapted in the light of new technical and scientific data and the experience gained;  Whereas, therefore, certain amendments must be made to the original text as soon as possible, but without detriment to the basic standards and principles of the system instituted by that Directive;  Whereas, in particular, certain vaccinations and tests need not be compulsory in the case of some categories of young animals;  Whereas, where it has not already been expressly indicated, the exact extent to which countries of destination have the right to assess the guarantees given by exporting countries should be specified;  Whereas, provision should be made for the possibility that trade in young bovine animals may be provisionally excluded ; subject to certain strict conditions, from certain general rules of the Directive;  Whereas the scope of the Directive must be defined as precisely as possible, in particular as regards certain marginal cases;  Whereas the Annexes to the Directive, particularly those concerned with the conditions relating to supervision on holdings and in the countries from which the animals come, should be amended in the light of progress made in controlling tuberculosis and brucellosis;  Whereas health certificates should be adapted to practical necessities, and any alterations required therein by reason of amendments to the Articles and Annexes should be made;  HAS ADOPTED THIS DIRECTIVE:    Article 1 The Council Directive of 26 June 1964 on animal health problems affecting intra-Community trade in bovine animals and swine shall be amended as indicated in the following Articles.   Article 2 The following shall be substituted for Article 2 (b):  "(b) "animal for slaughter" means a bovine animal or swine intended to be taken on arrival in the country of destination direct to a slaughterhouse or market."   1 OJ No 130, 19.7.1966, p. 2466/66.  2 OJ No 121, 29.7.1964, p. 1977/64.    Article 3 1. In Article 3 (2) (c) the words "or since birth" shall be inserted after the words "during the thirty days preceding loading" in both cases.  2. In Article 3 (2) (d) the word "mark" shall be substituted for the word "earmark".  3. In Article 3 (3) the following shall be inserted:    (a) in subparagraph (a) before the words "have been  vaccinated at least fifteen days" the words "in the  case of animals more than four months old";       (b) in subparagraph (b) after the words "in particular"  the words "in the case of animals more  than six weeks old";       (c) in subparagraph (c) after the words "in particular"  the words "in the case of animals more than twelve  months old".         4. In the third sentence of Article 3 (7) (c) the words "provided the provisions of paragraph 2 (e) are respected" shall be added after the words "these animals may".   Article 4 1. In Article 6 (3) the words "contagious or infectious disease" shall be substituted in each instance for the words "compulsorily notifiable disease".  2. The following shall be substituted for the first sentence of Article 6 (5):  "Animals for slaughter which have been taken on arrival in the country of destination direct to a slaughterhouse must be slaughtered there, as considerations of animal health require, as soon as possible."  3. The following subparagraph shall be inserted between the first and second subparagraphs of Article 6 (5):  "By way of derogation from the above provision and in specific cases Member States of destination may allow animals for slaughter to be sent to a market which does not adjoin a slaughterhouse."   Article 5 In Article 7 (1),    (a) the following new Section C shall be inserted after  Section B:  "C. Bovine animals for production less than thirty months old which by way of derogation from Article 3 (3) (c) do not come from an officially brucellosis-free or brucellosis-free bovine herd. Such animals must however have shown a brucella count of less than 30 international units of agglutination per millilitre when given a sero-agglutination test complying with the provisions of Annexes A and C. Such animals must bear a special mark. The Member State of destination must take all measures to avoid contamination of its own livestock. Not later than five years after the entry into force of this Directive, the Council, acting on a proposal from the Commission, shall decide whether the validity of this provision should be extended;"       (b) the former Section C shall become Section D.          Article 6 In Article 8,    (a) subparagraph (b) is hereby repealed and shall be  replaced by the following subparagraph (b):  "(b) the introduction into their territory for show purposes of animals for breeding or production, or of bulls for breeding for artificial insemination centres, provided that such provisions apply also to trade in such animals within the Member State and without prejudice to the provisions of this Directive relating to such animals;"       (b) the following subparagraph (c) shall be inserted:  "(c) bovine animals for breeding or production less than fifteen days old."          Article 7 1. Section I of Annex A shall be reworded as follows: I. Tuberculosis-free bovine animals and herds 1.  A bovine animal is considered to be tuberculosis-free  if:    (a) it comes from a bovine herd which is  officially tuberculosis-free within the  meaning of paragraph 2;       (b) it shows no clinical signs of tuberculosis;       (c) in the case of animals over six weeks  old,      (i) it shows no reaction to an intra-dermal  tuberculin test carried out in  accordance with Annex B not more  than thirty days before loading;           (ii) it shows no specific reaction.                      2.  A bovine herd is considered to be officially  tuberculosis-free if:    (a) all the animals are free from clinical signs  of tuberculosis;       (b) all the animals over six weeks old have  reacted negatively to at least two official  intradermal tuberculin tests carried out in  accordance with Annex B, the first one  six months after completion of disinfection  of the herd, the second one six  months later and the remainder at one-yearly  intervals. However if, in a Member  State whose entire bovine herd is under  official supervision, the percentage of holdings  infected with tuberculosis and containing  bovine animals is less than 1 %  during two successive periods of supervision  with a one-year interval, the interval  between tuberculin tests may be increased  to two years. If the proportion  of infected holdings is less than 0 72 %  during two successive periods of supervision  with a two-year interval, the interval  between tuberculin tests may be increased  to three years;       (c) no bovine animal has been introduced  without a certificate from an official veterinarian  showing that the animal comes  from an officially tuberculosis-free bovine  herd and, in the case of animals over  six weeks old, that it has reacted negatively  to an intradermal tuberculin test  assessed according to the criteria set out  in Annex B (21) (a).  Intradermal tuberculin testing shall not,  however, be required in Member States  in which the percentage of holdings infected  with tuberculosis and containing  bovine animals is less than 0 72 and if a  certificate from the official veterinarian  shows that the animal:      1. is properly identified;           2. comes from an officially tuberculosis-free  bovine herd within that Member  State;   3.  has not during transportation come  into contact with bovine animals which  do not come from officially tuberculosis-free  bovine herds."                2. Section II (A) (1) of Annex A shall be reworded as follows:  "1. A bovine animal is considered to be brucellosis-free if:    (a) it comes from a bovine herd which is officially  brucellosis-free within the meaning  of paragraph 2;       (b) it shows no clinical signs of that disease;       (c) in the case of animals over twelve months  old, its brucella count was less than 30  international units of agglutination per  millilitre when given a sero-agglutination  test carried out in accordance with Annex  C not more than thirty days before loading.  In addition, in the case of bulls over  eighteen months old, the sperm must not  contain brucella agglutinins."         3. Section II (A) (2) (d) of Annex A shall be reworded as follows:  "(d) no bovine animal has been introduced without a certificate from an official veterinarian showing that the animal comes from an officially brucellosis-free bovine herd and, in the case of animals over twelve months old, that its brucella count was less than 30 international units of agglutination per millilitre when given a sero-agglutination test not more than thirty days before it was taken into the herd.  Sero-agglutination testing shall not, however, be required in Member States in which the percentage of holdings infected with brucellosis and containing bovine animals is less than 0 72 % and if a certificate from the official veterinarian shows that the animal:    1. is properly identified;       2. comes from a bovine herd which is officially  brucellosis-free within that Member  State;       3. has not during transportation come into  contact with bovine animals which do not  come from officially brucellosis-free bovine  herds."          Article 8 1. Model 1 in Annex F shall be reworded as follows:  >PIC FILE= "T0019174">    >PIC FILE= "T0019175">    >PIC FILE= "T0019176">    2. Model II in Annex F shall be amended as follows:    (a) In the heading of the third column of the table in Section II the word "mark" shall be  substituted for the word "earmark" ; below the words "marks or brands" there shall be  inserted "(state No and position)";       (b) In the first line of Section V the following shall be omitted:      - in the French text : "Directeur départemental des services vétérinaires 5";           - in the Italian text : "Veterinario provinciale 5";           - in the Dutch text : "Distriktsinspecteur van de veeartsenijkundige Dienst 5";                  (c) The following indent shall be inserted at the beginning of paragraph (b) in Section V:  "-  They have been vaccinated within the prescribed period of not less than fifteen  days and not more than four months 7 against types A, O and C of foot-and-mouth  disease virus using an officially approved and tested inactivated vaccine 3;        (d) In the second indent in Section V (g) after the words "Member State" there shall be  inserted:  "..." ; (name of market)       (e) At the foot of the certificate "(signature) 5" shall be substituted for "Regional Director  of Veterinary Services 5";       (f) The following shall be substituted for the text of footnote 1:  "1 A Health Certificate may be issued only in respect of animals transported in a single railway wagon, lorry,  aircraft or boat from the same holding to the same consignee;"       (g) The following shall be substituted for the text of footnote 5:  "5 In Belgium : "Inspecteur vétérinaire" or "Diergeneeskundig inspecteur" ; in France : "Directeur départemental  des services vétérinaires" ; in Germany : "Beamteter Tierarzt" ; in Italy : "Veterinario provinciale" ; in  Luxembourg : "Inspecteur vétérinaire" ; in the Netherlands : "Distriktsinspecteur"."         3. Model III in Annex F shall be reworded as follows:  >PIC FILE= "T0019177">    >PIC FILE= "T0019178">    4. Model IV in Annex F shall be amended as follows:    (a) In the heading of the third column of the table in Section II the word "mark" shall  be substituted for the word "earmark" ; below the words "other marks or brands"  there shall be inserted "(state No and position)";       (b) In the first line of Section V the following shall be omitted:      - in the French text "Directeur départemental des services vétérinaires 5";           - in the Italian text : "Veterinario provinciale 5";           - in the Dutch text : "Distriktsinspecteur van de veeartsenijkundige Dienst 5";                  (c) In the second indent in Section V (c) after the words "Member State" there shall be  inserted:  "..." ; (name of market)       (d) At the foot of the certificate "(signature) 5" shall be substituted for "Regional Director  of Veterinary Services 5";       (e) The following shall be substituted for the text of footnote 1:  "1 A Health Certificate may be issued only in respect of animals transported in a single railway wagon, lorry,  aircraft or boat from the same holding to the same consignee";       (f) The following shall be substituted for the text of footnote 5:  "5 In Belgium : "Inspecteur vétérinaire" or "Diergeneeskundig inspecteur" ; in France : "Directeur départemental  des services vétérinaires" ; in Germany : "Beamteter Tierarzt" ; in Italy : "Veterinario provinciale" ; in  Luxembourg : "Inspecteur vétérinaire" ; in the Netherlands : "Distriktsinspecteur"."          Article 9 The Member States shall bring into force the laws, regulations and administrative provisions necessary to comply with this Directive within eight months following its notification and shall fortwith inform the Commission thereof.   Article 10 This Directive is addressed to the Member States.     Done at Brussels, 25 October 1966.  For the Council  The President  B.W. BIESHEUVEL


title: Commission Directive 2007/1/EC of 29 January 2007 amending Council Directive 76/768/EEC, concerning cosmetic products, for the purposes of adapting Annex II thereof to technical progress   (Text with EEA relevance)

text:
               1.2.2007

               EN

               Official Journal of the European Union

               L 25/9

         COMMISSION DIRECTIVE 2007/1/EC
   of 29 January 2007
   amending Council Directive 76/768/EEC, concerning cosmetic products, for the purposes of adapting Annex II thereof to technical progress
   (Text with EEA relevance)
   THE COMMISSION OF THE EUROPEAN COMMUNITIES,
   Having regard to the Treaty establishing the European Community,
   Having regard to Council Directive 76/768/EEC of 27 July 1976 on the approximation of the laws of the Member States relating to cosmetic products (1), and in particular Article 8(2) thereof,
   After consulting the Scientific Committee on Consumer Products (SCCP),
   Whereas:

               (1)

               Following the opinions of the SCCP issued on the basis of scientific studies, the Commission together with Member States and stakeholders agreed on an overall strategy to regulate hair dye substances according to which the industry was required to submit files with scientific data on hair dye substances to be evaluated by the SCCP.

               (2)

               The substances for which no explicit interest was expressed during the public consultation in defence of their use in hair dyes and for which no updated safety files were submitted to allow an adequate risk assessment should be included in Annex II.

               (3)

               The substance 4-amino-3-fluorophenol has until now been considered to be covered by the general entry, reference number 22, concerning aniline, its salts and its halogenated and sulphonated derivatives. However, as it is not obvious that 4-amino-3-fluorophenol belongs to that aniline family a specific entry for that substance should be included in Annex II.

               (4)

               For the sake of clarity, the substance epoxiconazole should be moved from the separate reference number 1182 to reference number 663 in Annex II to Directive 76/768/EEC.

               (5)

               As no new further scientific data were submitted to the SCCP before 31 July 2006 for the evaluation of N,N′-dihexadecyl-N,N′-bis(2-hydroxyethyl)propanediamide, that substance should be included in Annex II.

               (6)

               Directive 76/768/EEC should therefore be amended accordingly.

               (7)

               The measures provided for in this Directive are in accordance with the opinion of the Standing Committee on Cosmetic Products,

         HAS ADOPTED THIS DIRECTIVE:
   Article 1
   Annex II to Directive 76/768/EEC is amended in accordance with the Annex to this Directive.
   Article 2
   Member States shall ensure that with effect from 21 February 2008, cosmetic products which fail to comply with this Directive are not sold or disposed of to the final consumer.
   Article 3
   1.   Member States shall adopt and publish, by 21 August 2007 at the latest, the laws, regulations and administrative provisions necessary to comply with this Directive. They shall forthwith communicate to the Commission the text of those provisions and a correlation table between those provisions and this Directive.
   They shall apply those provisions from 21 November 2007.
   When Member States adopt those provisions, they shall contain a reference to this Directive or be accompanied by such a reference on the occasion of their official publication. Member States shall determine how such reference is to be made.
   2.   Member States shall communicate to the Commission the text of the main provisions of national law which they adopt in the field covered by this Directive.
   Article 4
   This Directive shall enter into force on the 20th day following its publication in the Official Journal of the European Union.
   Article 5
   This Directive is addressed to the Member States.

      Done at Brussels, 29 January 2007.

            For the Commission

         Günter VERHEUGEN

            Vice-President

      (1)  OJ L 262, 27.9.1976, p. 169. Directive as last amended by Commission Directive 2006/78/EC (OJ L 271, 30.9.2006, p. 56).
   ANNEX
   Annex II to Directive 76/768/EEC is amended as follows:

               1.

               The following reference numbers 1234 to 1243 are added:

                           Ref. No

                           Chemical name/INCI name

                           CAS No

                           ‘1234

                           PEG-3,2′,2′-di-p-Phenylenediamine

                           144644-13-3

                           1235

                           6-Nitro-o-Toluidine

                           570-24-1

                           1236

                           HC Yellow No 11

                           73388-54-2

                           1237

                           HC Orange No 3

                           81612-54-6

                           1238

                           HC Green No 1

                           52136-25-1

                           1239

                           HC Red No 8 and its salts

                           97404-14-3, 13556-29-1

                           1240

                           Tetrahydro-6-nitroquinoxaline and its salts

                           158006-54-3, 41959-35-7

                           1241

                           Disperse Red 15, except as impurity in Disperse Violet 1

                           116-85-8

                           1242

                           4-amino-3-fluorophenol

                           399-95-1

                           1243

                           N,N′-dihexadecyl-N,N′-bis(2-hydroxyethyl)propanediamide
                           Bishydroxyethyl Biscetyl Malonamide

                           149591-38-8’

               2.

               The entry under reference number 1182 is deleted.

               3.

               Reference number 663 is replaced by the following: ‘(2RS,3RS)-3-(2-Chlorophenyl)-2-(4-fluorophenyl)-[1H-1,2,4-triazol-1-yl)methyl]oxirane; epoxiconazole (CAS No 133855-98-8)’.


Avis juridique important

|

31993L0071

Commission Directive 93/71/EEC of 27 July 1993 amending Council Directive 91/414/EEC concerning the placing of plant protection products on the market

Official Journal L 221 , 31/08/1993 P. 0027 - 0036 Finnish special edition: Chapter 3 Volume 52 P. 0044  Swedish special edition: Chapter 3 Volume 52 P. 0044

COMMISSION DIRECTIVE 93/71/EEC of 27 July 1993 amending Council Directive 91/414/EEC concerning the placing of plant protection products on the marketTHE COMMISSION OF THE EUROPEAN COMMUNITIES,  Having regard to the Treaty establishing the European Economic Community,  Having regard to Council Directive 91/414/EEC of 15 July 1991 concerning the placing of plant protection products on the market (1), and in particular Article 18 (2) thereof,  Whereas Annexes II and III to Directive 91/414/EEC lay down the requirements for the dossier to be submitted by applicants respectively for the inclusion of an active substance in Annex I and for the authorization of a plant protection product;  Whereas it is necessary to indicate to applicants in Annexes II and III, as precisely as possible, the details of the required information, such as the circumstances, conditions and technical protocols under which certain data have to be generated;  whereas these provisions should be introduced as soon as available in order to permit applicants to use them in the preparation of their dossiers;  Whereas greater precision can be given at the present time to the general introductionary provisions to Annexes II and III and to the data requirements concerning efficacy testing provided for in Section 6 of Parts A and B of Annex III;  Whereas the introductions to the Annexes II and III currently refer to the application of the principles of good laboratory practice (GLP) for any data requirements; whereas, however, the application of such principles is not considered to be  appropriate for efficacy testing and for the testing of certain physico-chemical properties or other information which are not related to data on the properties and/or safety with respect to human or animal health or the environment;  Whereas moreover it is necessary to provide for a temporary exemption of the application of these principles for certain data requirements to permit the laboratories concerned to adapt themselves to the requirements of GLP;  Whereas the specific European and Mediterranean Plant Protection Organization (EPPO) guidelines constitute for the time being the best available basis for setting the minimum requirements to be applied in all Member States with regard to the guidelines  used for efficacy testing, whereas it appears necessary however to proceed urgently to a detailed examination of these guidelines and to provide for higher standards in Directive 91/414/EEC in cases where certain guidelines would appear inadequate for  efficacy testing;  Whereas the measures provided for in this Directive are in accordance with the opinion of the Standing Committee on Plant Health,  HAS ADOPTED THIS DIRECTIVE:  Article 1  Directive 91/414/EEC is amended as follows:  1. the section headed 'Introduction' in Annex II is replaced by Annex I hereto;  2. the section headed 'Introduction' in Annex III is replaced by Annex II hereto,  3. Section 6 headed 'Efficacy data' in both Parts A and B of Annex III is replaced by Annex III hereto.  Article 2  Member States shall bring into force the laws, regulations and administrative provisions necessary to comply with this Directive within twelve months following notification thereof. They shall immediately inform the Commission thereof.  When Member States adopt these measures, these shall contain a reference to this Directive or shall be accompanied by such reference at the time of their official publication. The procedure for such reference shall be adopted by Member States.  Article 3  This Directive is addressed to the Member States.  Done at Brussels, 27 July 1993.  For the Commission René STEICHEN Member of the Commission (1) OJ No L 230, 19. 8. 1991, p. 1.    ANNEX I 'INTRODUCTION The information required shall:  1.1. include a technical dossier supplying the information necessary for evaluating the foreseeable risks, whether immediate or delayed, which the substance may entail for humans, animals and the environment and containing at least the information and  results of the studies referred to below;  1.2. where relevant, be generated using test guidelines referred to or described in this Annex, in the case of studies initiated before the adoption of the modification of this Annex, the information shall be generated using suitable internationally or  nationally validated test guidelines or, in the absence thereof, test guidelines accepted by the competent authority;  1.3. in the event of a test guideline being inappropriate or not described, or where another one than those referred to in this Annex has been used, inlcude a justification, which is acceptable to the competent authority for the guidelines used;  1.4. include, when required by the competent authority, a full description of test guidelines used, except if they are referred to or described in this Annex, and a full description of any deviations from them including a justification, which is  acceptable to the competent authority, for these deviations;  1.5. include a full and unbiased report of the studies conducted as well as full description of them or a justification, which is acceptable to the competent authority where:  - particular data and information which would not be necessary owing to the nature of the product or its proposed uses, are not provided,  or - it is not scientifically necessary, or technically possible to supply information and data;  1.6. where relevant, have been generated in accordance with the requirements of Directive 86/609/EEC.  2.1. Tests and analyses must be conducted in accordance with the principles laid down in Directive 87/18/EEC (1) where testing is done to obtain data on the properties and/or safety with respect to human or animal health or the environment.  2.2. By way of derogation from point 2.1, tests and analyses done to obtain data on the properties and/or safety with respect to honeybees and beneficial arthropods other than bees may have been conducted by official or officially recognized testing  facilities or organizations which satisfy at least the requirements as set out under points 2.2 and 2.3 of the introduction to Annex III.  This derogation expires on 31 December 1999.  (1) OJ No L 15, 17. 1. 1987, p. 29.'   ANNEX II 'INTRODUCTION The information required shall:  1.1. include a technical dossier supplying the information necessary for evaluating efficacy and the foreseeable risks, whether immediate or delayed, which the plant protection product may entail for humans, animals and the environment and containing at  least the information and results of the studies referred to below;  1.2. where relevant, be generated using test guidelines referred to or described in this Annex; in the case of studies initiated before the adoption of the modification of this Annex, the information shall be generated using suitable internationally or  nationally validated test guidelines or, in the absence thereof, test guidelines accepted by the competent authority;  1.3. in the event of a test guideline being inappropriate or not described, or where another one than those referred to in this Annex has been used, include a justification, which is acceptable to the competent authority for the guidelines used;  1.4. include when required by the competent authority, a full description of test guidelines used, except if they are referred to or described in this Annex, and a full description of any deviations from them including a justification, which is  acceptable to the competent authority, for these deviations;  1.5. include a full and unbiased report of the studies conducted as well as a full description of them or a justification, which is acceptable to the competent authority where:  - particular data and information which would not be necessary owing to the nature of the product or its proposed uses, are not provided,  or - it is not scientifically necessary, or technically possible to supply information and data.  1.6. where relevant, have been generated in accordance with the requirements of Directive 86/609/EEC.  2.1. Tests and analyses must be conducted in accordance with the principles laid down in Directive 87/18/EEC where testing is done to obtain data on the properties and/or safety with respect to human or animal health or the environment.  2.2. Tests and analyses, required under the provisions of Section 6 points 6.2 to 6.7 of this Annex, shall be conducted by official or officially recognized testing facilites or organizations which satisfy at least the following requirements:  - have at their disposal sufficient scientific and technical staff, having the necessary education, training, technical knowledge and experience for their assigned functions,  - have at their disposal suitable items of equipment required for correct performance of the tests and measurements which it claims to be competent to carry out. This equipment shall be properly maintained and calibrated where appropriate before being  put into service and thereafter according to an established programme,  - have at their disposal appropriate experimental fields and, where necessary glasshouses, growth cabinets or storage rooms. The environment in which the tests are undertaken shall not invalide its results or adversely effect the required accuracy of  measurement,  - make available to all relevant personnel operating procedures and protocols used for the trials,  - make available, where requested by the competent authority, prior to the commencement of a test, detailed information on it, containing at least its location and the plant protection products included in it,  - ensure that the quality of the work performed is appropriate to its type, range, volume and intended purpose,  - calibration records and the final test report as long as the product concerned authorized in the Community.  2.3. Member States shall require that officially recognized testing facilities and organizations, and, where requested, official facilities and organizations:  - report to the relevant national authority all detailed information necessary to demonstrate that they can satisfy the requirements provided for in point 2.2,  - accept at any time the inspections, which each Member State shall regularly organize on its territory in order to verify the compliance with the requirement as laid down in point 2.2.  2.4. By way of derogation from point 2.1 the provisions of points 2.2 and 2.3 also apply until 31 December 1999 for the tests and analyses done to obtain data on the properties and/or safety with respect to honeybees and beneficial arthropods other than  bees.  3. The information required shall include the proposed classification and labelling of the plant protection product in accordance with relevant Community Directives.  4. In individial cases it may be necessary to require certain information as provided for in Annex II, Part A, for formulants. Before such information will be required and before possible new studies have to be performed, all information on the  formulant, made available to the competent authority, will be considered, in particular when:  - the use of the formulant is permitted in food, animal feeding stuffs, medicines or cosmetics in accordance with Community legislation,  or - a safety data sheet has been submitted for the formulant in accordance with Council Directive 67/548/EEC.'  ANNEX III '6. Efficacy data General The data supplied must be sufficient to permit an evaluation of the plant protection product to be made. In particular it must be possible to evaluate the nature and extent of benefits that accrue following use of the preparation, where they exist in  comparison to suitable reference products and damage thresholds, and to define its conditions of use.  The number of trials to be conducted and reported depends mainly on factors such as the extent to which the properties of the actieve substance(s) it contains are known and on the range of conditions that arise, including variability in plant health  conditions, climatic differences, the range of agriculral practices, the uniformity of the crops, the mode of application the type of harmful organism and the type of plant protection product.  Sufficient data must be generated and submitted to confirm that patterns determined hold for the regions and the range of conditions, likely to be encountered in the regions concerned, for which its use is to be recommended. Where an applicant claims  that tests in one or more of the proposed regions of use are unnecessary because conditions are comparable with those in other regions where tests have been carried out, the applicant must substantiate the claim for comparability with documentary  evidence.  In order to assess seasonal differences, if any, sufficient data must be generated and submitted to confirm the performance of the plant protection product in each agronomically and climatically different region for each particular crop (or  commodity)/harmful organism combination. Normally trials on effectiveness or phytotoxicity, where relevant, in at least two growing seasons must be reported.  If to the opinion of the applicant the trials from the first season adequately confirm the validity of claims made on the basis of extrapolation of results from other crops, commodities or situations or from tests with closely similar preparations, a  justification, which is acceptable to the competent authority for not carrying out a second seaons's work must be provided. Conversely, where, because of climatic or plant health conditions or other reasons the data obtained in any particular season are  of limited value for the assessment of performance, trials in one or more further seasons must be conducted and reported.  6.1. Preliminary tests Reports in summary form of preliminary tests, including glasshouse and field studies, used to assess the biological activity and dose range finding of the plant protection product and of the active substance(s) it contains, must be submitted when  requested by the competent authority. These reports will provide additional information for the competent authority when it evaluates the plant production product. Where this information is not submitted a justification which is acceptable to the  competent authority must be provided.  6.2. Testing effectiveness Aim of the tests The tests shall provide sufficient data to permit an evaluation of the level, duration and consistency of control or protection or other intended effects of the plant protection product in comparison to suitable reference products, where they exist.  Test conditions Normally a trial consists of three components: test product, reference product and untreated control.  The performance of the plant protection product must be investigated in relation to suitable reference products, where they exist. A suitable reference product is defined as an authorized plant protection product which has proved a sufficient  performance in practice under the agricultural, plant health and environmental (including climatic) conditions in the area of proposed use. In general, formulation type, effects on the harmful organisms, working spectrum and method of application should  be close to those of the tested plant protection product.  Plant protection products must be tested in circumstances where the target harmful organism has been shown to have been present at a level causing or known to cause adverse effects (yield, quality, operational benefit) on an unprotected crop or area or  on plants or plant products which have not been treated or where the harmful organism is present at such a level that an evaluation of the plant protection product can be made.  Trials to provide data on plant protection products for control of harmful organisms must show the level of control of the species of harmful organisms concerned or of species representative of groups for which claims are made. Trials must include the  different stages of growth of life cycle of the harmful species, where this is relevant and the different strains or races, where these are likely to show different degrees of susceptibility.  Similarly, trials to provide data on plant protection products which are plant growth regulators, must how the level of effects on the species to be treated, and include investigation of differences in the response of a representative sample of the  range of cultivars on which its use is proposed.  In order to clarify the dose response, dose rates lower than the recommended one must be included in some trials in order to enable to assess whether the recommended rate is the minimum necessary to achieve the desired effect.  The duration of the effects of treatment must be investigated in relation to the control of the target organism or effect on the treated plants or plant products, as appropriate. When more than one application is recommended, trials must be reported  which establish the duration of the effects of an application, the number of applications necessary and the desired intervals between them.  Evidence must be submitted to show that the dose, timing and medthod of application recommended give adequate control, protection or have the intended effect in the range of circumstances likely to be encountered in practical use.  Unless there are clear indications that the performance of the plant protection production is unlikely to be affected to a significant degree by environemental factors, such as temperature or rain, an investigation of the effects of such factors on  performace must be carried out and reported, particularly where it is known that the performance of chemically related products os so affected.  Where proposed label claims include recommendations for the use of the plant protection product with other plant protection product(s) or adjuvant(s) information on the performance of the mixture must be provided.  Test guideline Trials must be designed to investigate specified issues, to minimize the effects of random variation between different parts of each site and to enable statistical analysis to be applied to results amenable to such analysis. The design, analysis and  reporting of trials must be in accordance with European and Mediterranean Plant Protection Organization (EPPO) guidelines 152 and 181. The report shall include a detailed and critical assessment of the data.  The trials must be carried out in accordance to specific EPPO guidelines, where available, or when a requires so and when the test is carried out on the territory of this, with guidelines satisfying at least the requirements of the corresponding EPPO  guideline.  A statistical analysis of results amenable to such analysis must be carried out; where necessary the test guideline used must be adapted to enable such analysis.  6.3. Information on the occurrence or possible occurrence of the development of resistance Laboratory data and where it exists, field information relating to the occurrence and development of resistance or cross-resistance in populations of harmful organisms to the active substance(s), or to related actived substances, must be provided. Where  such information is not directly relevant to the uses for which authorization is ought or to be renewed (different species of harmful organism or different crops), it must, if available, nevertheless be provided, as it may provide and indication of the  likelihood of resistance developing in the target population.  Where there is evidence or information to suggest that, in commercial use, the development of resistance is likely, evidence must be generated and submitted as to the sensitivity of the population of the harmful organism concerned to the plant  protection product. In such cases a management strategy designed to minimize the likelihood of resistance or cross-resistance developing in target species must be provided.  6.4. Effects on the yield of treated plants or plant products in terms of quantity and/or quality 6.4.1. Effects on the quality of plants or plant product Aim of the tests The tests shall provide sufficient data to permit an evaluation of the possible occurrence of taint or odour or other quality aspects of plants or plant products after treatment with the plant protection product.  Circumstances in which required The possibility of the occurrence of taint or odour in food crops must be investigated and be reported where:  - the nature of the products or its use is such that a risk of occurrence of taint or odour might be expected,  or - other products based on the same or a closely similar active ingredient have been shown to present a risk of occurrence of taint or odour.  The effects of plant protection products on other quality aspects of treated plants or plant products must be investigated and reported where:  - the nature of the plant protection product or it use could have an adverse influence on other quality aspects (for example in the case of use of plant growth regulators close or harvest), or - other products based on the same or a closely similar active ingredient have been shown to have an adverse influence on the quality.  Testing should be conducted initially on the main crops on which the plant protection product is to be used, at twice the normal rates of application and using, where relevant, the main methods of processing. Where effects are observed it is necessary  to perform testing at the normal rate of application.  The extent of investigation necessary on other crops will depend on their degree of similarity of the main crops already tested, the quantity and quality of data available on those main crops and how far the manner of use of the plant protection product  and methods of processing the crops, are similar. It is generally sufficient to perform the test with the main formulation type to be authorized.  6.4.2. Effects on transformation processes Aim of the tests The tests shall provide sufficient data to permit an evaluation of the possible occurrence of adverse effects after treatment with the plant protection product on transformation processes or on the quality of their products.  Circumstances in which required When the treated plants or plant products are normally intended for use in transformation process such as wine making, brewing or bread making and when at harvest significant residues are present, the possibility of the occurrence of adverse effects  must be investigated and reported where:  - there are indications that the use of the plant protection product could have an influence on the processes involved (for example in the case of use of plant growth regulators or fungicides close to harvest),  or - other products based on the same or a closely similar active ingredient have been shown to have an adverse influence on these processes or its products.  It is generally sufficient to perform the test with the main formulation type to be authorized.  6.4.3. Effects on the yield of treated plants or plant products Aim of the tests The test shall provide sufficient data to permit an evaluation of the performance of the plant protection product and of possible occurrence of yield reduction or loss in storage of treated plants or plant products.  Circumstances in which required The effects of plant protection products on the yield or yield components of treated plant products must be determined where relevant. When treated plants or plant products are likely to be stored the effect on the yield after storage, including data on  starage life must be determined where relevant.  This information will normally be available from the tests required under the provisions of point 6.2.  6.5. Phytotoxicity to target plants (including different cultivars), or to target plant products Aim of the tests The test shall provide sufficient data to permit an evaluation of the performance of the plant protection product and of the possible occurrence of phytotoxicity after treatment with the plant protection product.  Circumstances in which required For herbicides and for other plant protection products for which adverse effects, however transitory, are seen during the trials, performed in accordance to point 6.2, the margins of selectivity on target crops must be established, using twice the  recommended rate of application. Where serious phytotoxic effects are seen, an intermediate application rate must also be investigated.  Where adverse effects occur, but are claimed to be unimportant in comparison with the benefits of use or transient, evidence to support this claim is required. If necessary yield measurement must be submitted.  The safety of a plant protection product to the main cultivars of the main crops for which it is recommended must be demonstrated, including effects of crop growh stage, vigour, and other factors which may influence suspectibility to damage or injury.  The extent of investigation necessary on other crops will depend on their degree of similarity to the main crops already tested, the quantity and quality of data available on those main crops and how far the manner of use of the plant protection  product, if relevant, is similar. It is generally sufficient to perform the test with the main formulation type to be authorized.  Where proposed label claims include recommendations for the use of the plant protection product with other plant protection product(s), the provisions of the previous paragraphs apply for the mixture.  Test guideline Observations concerning phytotoxicity must be performed in the tests provided for under point 6.2.  Where phytotoxic effects are seen, they must be accurately assessed and recorded in accordance with EPPO guideline 135 or when a Member State requires so and when the test is carried out on the territory of this Member State, with guidelines satisfying  at least the requirements of this EPPO guideline.  A statistical analysis of results amenable to such analysis must be carried out, where necessary the test guideline used must be adapted to enable such analysis.  6.6. Observations on undesirable or unintended side-effects, e. g. on beneficial and other non-target organisms, on succeeding crops, other plants or parts of treated plants used for propagating purposes (e. g. seeds, cuttings, runners) 6.6.1. Impact on succeeding crops Aim of the information required Sufficient data must be reported to permit an evaluation of possible adverse effects of a treatment with the plant protection product on succeeding crops.  Circumstances in which required Where data, generated in accordance with Section 9, point 9.1, shows that signification residues of the active substance, its metabolites or degradation products, which have or may have biological activity on succeeding crops, remain in soil or in plant  materials, such as straw or organic material up to sowing or planting time of possible succeeding crops, observations must be submitted on effects on the normal range of succeedings crops.  6.6.2. Impact on other plants, including adjacent crops Aim of the information required Sufficient data must be reported to permit an evaluation of possible adverse effects of a treatment with the plant protection product on other plants, including adjacent crops.  Circumstances in which required Observations must be submitted on adverse effects on other plants, including the normal range of adjacent crops, when there are indications that the plant protection product could affect these plants via vapour drift.  6.6.3. Impact on treated plants or plant products to be used for propagation Aim of the information required Sufficient data must be reported to permit an evaluation of possible adverse effects of a treatment with the plant protection product on plants or plant products ot be used for propagation.  Circumstances in which required Observations must be submitted on the impact of plant protection products on plant parts used for propagation except where the proposed uses preclude use on crops intended for production of seeds, cuttings, runners or tubers for planting, as  appropriate.  (i) for seeds - viability, germination and vigour;  (ii) cuttings - rooting and growth rates;  (iii) runners - establishment and growth rates;  (iv) tubers - sprouting and normal growth.  Test guideline Seeds testing shall be done according to ISTA Methods (1).  6.6.4. Effects on beneficial and other non-target organisms Any effects, positive or negative, on the incidence of other harmful organisms, observed in the tests performed in accordance with the requirements of this section, shall be reported. Any observed environmental effects must also be reported, especially  effects on wildlife and/or beneficial organisms.  6.7. Summary and evaluation of data presented under 6.1 to 6.6 A summary of all data and informations provided under points 6.1 to 6.6 must be provided, together with a detailed and a critical assessment of the data, with particular reference to the benefits that the plant protection product offers, adverse effects  that do or may arise and measures necessary to avoid or minimize adverse effects.' (1) International rules for seed testing, 1985. Proceedings of the International Seed Testing Association, Seed Science and Technology, Volume 13, No 2, 1985.